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Abstract The present study examines whether nitrogen dioxide 
(RO&induced activation of protein kinase C (PKC) is 
associated with increased expression of specific PKC isoforms 
and/or with enhanced generation of phosphatidylcholine(PC)- 
derived diacylglycerol (DAG) in pulmonary artery endothelial 
cells (PAEC). Western blot analysis revealed that exposure to 
5 ppm NO2 resulted in increased expression of PKC a and E 
isoforms in both cytosol and membrane fractions in a time- 
dependent fashion compared with controls. A time-dependent 
elevated expression of PKC isoform B was observed in the cytosol 
fraction only of NOz-exposed cells. PKC isoform y was not 
detectable in either the cytosolic or membrane fractions from 
control or NO+xposed cells. Scatchard analysis of [3H]phorbol 
12,13dibutyrate (PDBu) binding showed that exposure to NO* 
for 24 h increased the maximal number of binding sites (B,,,,,) 
from 15.2 f 2.3 pmollmg (control) to 42.3& 5.3 pmollmg 
(p < 0.01, n = 4) (NO*-exposed). Exposure to NO2 significantly 
increased PC specific-phospholipase C and phospholipase D 
activities in the plasma membrane of PAEC (p < 0.05 and 
p : 0.001, respectively). When [‘Hlmyristic acid-labeled cells 
were exposed to NO*, significantly increased radioactivity was 
associated with cellular DAG. These results show for the first 
time that exposure of PAEC to NO2 results in elevated 
expression of specific PKC isoforms and in enhanced generation 
of cellular DAG, and the latter appears to arise largely from the 
hydrolysis of plasma membrane PC. 
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1. Introduction 
Nitrogen dioxide (NO& a major indoor and outdoor oxi- 
di‘tive environmental pollutant, is known to cause injury to 
lu,lg cells, including endothelial cells, in vitro [l-S] and in vivo 
[6 71. For example, Richters and Richters [2] have reported 
m,,rphologic changes in lung capillary endothelial cells of 
m ce exposed to NOz. Similarly, in a more recent study of 
canine lungs, damage to endothelial cells after NOz exposure 
w.ts identified [3]. Recent reports from this laboratory have 
shown that NO2 exposure results in activation of protein ki- 
n;:se C (PKC) [7] and in increased biosynthesis of phosphati- 
d>lserine (PS) [8] an essential phospholipid required for PKC 
activity, in cultured pulmonary artery endothelial cells 
(P4EC). PKC plays a central role in mediating signal trans- 
dl,ction in cells and exists as a family of closely related iso- 
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zymes. To date, more than 10 members of the PKC family 
have been identified in mammalian tissues [9]. Although the 
function of all known PKC isoforms is dependent on PS, 
some isoforms are specifically activated by sn- 1,2-diacylglycer- 
01 (DAG) [9]. PKC isoforms have also been reported to have 
tissue-specific distribution across species [9]. The formation of 
DAG independent of phosphatidylinositol hydrolysis by ago- 
nist-stimulated cells could be the result of either a direct phos- 
pholipase C (PLC)-mediated mechanism hydrolyzing phopha- 
tidylcholine (PC) or an indirect mechanism that sequentially 
forms DAG through combined phospholipase D (PLD)/pho- 
phatidic acid (PA) phosphohydrolase activity [lo, 111. In gen- 
eral, increased hydrolysis of PC results in more sustained 
DAG production and is stimulated by both receptor-mediated 
agonists and other chemical stimuli [9%11]. 
The distribution and expression of PKC isoforms in lung 
endothelial cells is not known. Similarly, the mechanism re- 
sponsible for the NOZ-induced increased in PKC activity is 
unknown. However, it is possible that expression of specific 
PKC isoforms and/or the cellular availability of DAG may 
play crucial roles in activation of PKC in NOz-exposed 
PAEC. To elucidate the mechanisms of PKC activation by 
exposure to NO*, we examined (i) whether NO*-induced 
PKC activation is associated with increased expression of spe- 
cific PKC isoforms and (ii) whether exposure to NO2 activates 
plasma membrane PLC and PLD, resulting in enhanced gen- 
eration of PC-derived DAG, an essential co-factor for PKC 
activation in PAEC. We chose endothelial cells as a model for 
two reasons. First, NO2 exposure is known to cause morpho- 
logic alterations in endothelial cells of mammalian lungs [l-5]. 
Second, observations relating to N02-induced alterations in 
signal transduction identified in endothelial cells are likely to 
be applicable to other lung cells injured by NO2 exposure. 
2. Materials and methods 
2. I. Cell culture and labeling of’ cell phospholipiris 
Endothelial cells were obtained from the main pulmonary artery of 
6&7-month-old pigs as described by Pate1 et al. [7] and propagated in 
monolayer cultures in loo-mm culture dishes. Third- to sixth-passage 
cells in postconfluent monolayers maintained in RPM1 1640 medium 
(Gibco, Grand Island, NY) with 4% fetal bovine serum (ICN Bio- 
chemical Inc., Costa Mesa, CA) and antibiotics (maintenance med- 
ium) were used for all experiments. Cells were studied 1 or 2 days 
after confluence and were matched in each experiment for confound- 
ing tissue culture variables, i.e. cell line, number of subcultures, time 
of monolayer confluence, and number of days postconfluence. In 
some experiments, cell phospholipids were labeled by incubating cell 
monolayers for 24 h with [3H]myristic acid (1 pCi/ml medium) (14.0 
Ci/mmol, NEN, DuPont, Boston, MA) in 5 ml of medium. After 
labeling, cells were washed twice with RPM1 1640 medium and 
were then maintained in 10 ml of fresh maintenance medium until 
further use. 
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2.2. Exposure to NO2 
Confluent monolayers of unlabeled or [3H]myristic acid-labeled en- 
dothelial cells in 10 ml of fresh maintenance medium were exposed to 
a continuous flow of 5 ppm NOs in air containing 5% COs for 448 h 
as described earlier [6]. An equal number of matched dishes (i.e. 
matched for confounding tissue culture variables) were exposed to 
air containing 5% COs and served as controls. After exposure, cells 
were used for identification of PKC isoforms, quantitation of phorbol 
ester binding, isolation of plasma membranes, and measurement of 
plasma membrane-specific PLC and PLD activities. 
The concentration of NOa used in this study, 5 ppm, is higher than 
the ambient concentration. However, NOs has a limited solubility in 
an aqueous medium; therefore, the amount of NOz directly interact- 
ing with the cells is much less than the 5 ppm flowing into the ex- 
posure chamber. We have previously reported that under our experi- 
mental conditions approx. 30% of NOs is soluble in the culture 
medium [6]. In addition, comparable effects of exposure to NO2 
were observed whether cell monolayers were incubated in RPM1 
1640 or Hanks’ balanced salt solution [6]. 
2.3. IdentiJication of PKC isoforms by immunoblotting 
Immediately after NOs exposure, cells were homogenized and cyto- 
sol and membrane fractions were isolated by differential centrifuga- 
tion as previously described [7]. Cytosol and membrane fraction PKC 
were partially purified from both NOz-exposed and control cells ac- 
cording to the procedure described by Pate1 et al. [7]. Equal amounts 
of protein from cytosol and membrane fractions were separated by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) on a 7.5% gel and were then transferred by electroblotting 
onto nitrocellulose membranes (Bio-Rad, Hercules, CA). PKC iso- 
forms (C@,y,E) were identified with isotype-specific antibodies (GIB- 
CO, Gaithersburg, MD) and were visualized by an enhanced chemi- 
luminescence detection system (ECL) (Amersham, Arlington Height, 
IL). The blots were scanned using a laser densitometer (Ultrascan XL, 
LKB, Bronma, Sweden) to quantify PKC isoform protein contents. 
2.4. Quantitation of phorbol ester binding 
Phorbol ester binding was performed according to the procedure 
described by Huang et al. [12] with minor modifications. In brief, cell 
monolayers from both 24 h NOs-exposed and control cells were col- 
lected in physiological saline solution and pelleted by centrifugation at 
25OXg for 5 min. Cells were homogenized in 29 mM Tris-HCl buffer 
(pH 7.5) containing 2 mM EDTA, 5 mM EGTA, 100 pg leupeptitiml, 
1 mM phenyhnethylsulfonyl fluoride, 250 mM sucrose, and 0.1% 
2-mercaptoethanol. Total [3H]phorbol 12,13-dibutyrate (PDBu) bind- 
ing was measured in an assay mixture containing 50 pl of homogenate 
(SCrlOO pg protein), 20 @ml PS, 20 mM Tris-HCl, pH 7.5, 20 mM 
magnesium acetate, 2.5 mM CaCls, 0.5 mg/ml of bovine serum albu- 
min, and 2-100 nM [3H]PDBu in a final volume of 200 ul. Nonspecific 
binding was measured in the presence of 30 pM unlabeled PDBu. 
Samples were incubated at 25°C for 15 min, and then 0.5 ml of a 
30% solution of DEAE-cellulose in 20 mM Tris-HCl @H 7.5, 4°C) 
was added. After incubation for 30 min at 4”C, samples were filtered 
under negative pressure through Whatman GFlC filters and washed 
10 times with 4 ml ice-cold 20 mM Tris-HCl (pH 7.5). Radioactivity 
on the filters was measured by a liquid scintillation counter. Specific 
binding of PDBu was determined by subtracting non-specific binding 
from total binding. Under our experimental conditions, specific bind- 
ing was 96 + 3% (at 2 nM [3H]PDBu, n = 4) and 83 & 4% (at 100 nM 
[3H]PDBu, n = 4) of total binding. 
2.5. Measurement of plasma membrane-specific PLC and PLD 
activities 
Plasma membranes were isolated from 24 h NOs-exposed and con- 
trol cells as described earlier [8]. Immediately after isolation, plasma 
membranes were used to measure PLC and PLD activities. 
2.6. PLC assay 
Phospholipase C activity was assayed as described by Martin et al. 
[ 131 with minor modification. In brief, the reaction mixture contained 
100 mM HEPES, 100 mM sodium acetate, 1 mM EDTA, 2 mM 
CaClz (pH 7.5), 10 pM PC, and L-o-[1-14C]dioleoyl-PC (50000 dpm) 
(NEN, Du Pont, Wilmington, DE) in a final volume of 300 ~1. The 
reaction was initiated by adding 10 pl of plasma membrane (20 ug 
protein) and then incubated at 37°C in a shaker water bath for 1 h. 
The reaction was terminated by adding 1.0 ml of chloroform/metha- 
nol (2: 1, v/v) containing 36 mM HCl. The lipid phase was dried and 
separated by thin-layer chromatography (TLC). Authentic DAG was 
co-chromatographed to identify DAG. Spots corresponding to DAG 
were scraped, and radioactivity was quantified by liquid scintillation 
spectrometry. 
2.7. PLD assay 
Phospholipase D activity in plasma membranes isolated from con- 
trol or 24 h NOs-exposed cells was determined by release of 
[3H]choline from a [3H]choline-labeled phosphatidylcholine substrate 
as described by Martin [14] and Huang and Cabot [15]. In brief, the 
reaction mixture contained 50 mM HEPES, 40 mM NaCl, 2 mM 
EDTA, 0.05% Triton-X-100 (pH 7.5), 0.5% ethanol, and 20 nM PC 
with L-a-diualmitovllcholine-methvl-3H1PC (50 000 dnm) (NEN. Du- 
Pont, Wilmmgton, DE) in a final’volume of 200 pl. The reaction was 
initiated by adding 10 pl of plasma membrane (20 pg protein), and 
then the mixture was incubated at 37°C for 1 h. The reaction was 
terminated by adding 0.6 ml of chloroform/methanol (2:1 v/v) con- 
taining 60 mM HCl. The aqueous phase was dried and separated by 
TLC. Authentic choline was co-chromatographed to identify choline. 
Spots corresponding to choline were scraped, and radioactivity was 
quantified by liquid scintillation spectrometry. 
2.8. Quantitation of PC-derived cellular DAG 
As described above, endothelial cell monolayers were labeled with 
[3H]myristic acid for 24 h. The same number of matched and labeled 
cells were exposed to NO2 or served as controls. Immediately after 
exposure, total lipids were extracted from both NOs-exposed and 
control cells using the procedure of Bligh and Dyer [16]. DAG was 
separated by TLC, and DAG-associated radioactivity was measured 
by liquid scintillation spectrometry as described by Martin et al. [13]. 
2.9. Statistical analysis 
Data were analyzed using analysis of variance (ANOVA) and Stu- 
dent’s t-test [17]. The significant difference test was performed using 
the True Epistate program (True Epistate, Epistate Service, Richard- 
son, TX). 
3. Results 
Exposure to 5 ppm NO* for 4-48 h had no significant effect 
on endothelial cell morphology assessed by phase contrast 
microscopy. Similarly, protein contents of cell homogenates 
or isolated plasma membranes from NOz-exposed cells were 
comparable to controls (data not shown). 
3.1. Effect of NO2 exposure on expression of spectjic PKC 
isoforms 
Because exposure to NO2 increases total PKC activity [7], 
we examined whether NO2 selectively increases the expression 
of specific PKC isoforms. We used PKC isoform-specific anti- 
bodies directed against isoforms a, B, and y (classical PKC 
isoforms, both calcium and DAG dependent) and isoform E 
(calcium independent, DAG dependent) for immunodetection. 
After exposure to NOz, PKC in both cytosol and membrane 
fractions were partially purified and probed with PKC a,g,y 
and s-specific antibodies. As shown in Fig. 1, expressions of 
PKC isoforms a and E were detectable by immunoblotting in 
both cytosol and membrane fractions, PKC isoform I3 was 
detectable only in the cytosol fraction, and isoform y was 
not detectable in either cytosol or membrane fractions. As 
shown in a representative autoradiograph (Fig. 1) and accom- 
panying densitometric analysis of the data (Fig. 2), exposure 
to NOz resulted in increased expression of PKC a and E iso- 
forms in both the cytosol and membrane fractions in a time- 
dependent fashion compared with controls. A time-dependent 
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elevated expression of PKC isoform I3 was observed in the 
cytosol fraction. 
3..?. NO2 exposure increases phorbol ester binding 
Phorbol esters (e.g. PDBu), a group of tumor-promoting 
agents, are known to bind to PKC with high affinity and 
specificity [18]. This binding characteristic of PDBu is used 
tc evaluate catalytic activity and expression of PKC proteins 
[l 1. Therefore, we examined whether binding of [3H]PDBu 
w ts increased in 24-h NOz-exposed endothelial cells. As 
shown in Fig. 3, Scatchard analysis of [3H]PDBu binding to 
er dothelial cell homogenates showed a single population of 
bmding sites with no significant difference in the equilibrium 
di ;sociation constant (&) between control (366 f 67 nM) and 
NJ&-exposed cells (402 rt 54 nM, n = 4). However, a 24-h ex- 
PC ‘sure to NOz increased the maximal number of binding sites 
(r.,,) from 15.2 f 2.3 pmol/mg (control) to 42.3 + 5.3 pmoV 
m ; (NO2 exposed) (p<O.Ol, n=4). 
3. :. NO2 exposure increases plasma membrane PC-specific 
PLC and PLD activities 
All isoforms of PKC identified in our PAEC are known to 
bt activated by DAG [9]. Because a variety of external stimuli 
ai : known to increase DAG production by PLC- and/or 
Pi ,D-mediated hydrolysis of phosphatidylinositol 4,5-biphos- 
pl ate (PI) or PC in vascular endothelial cells [l 11, we deter- 
mmned whether exposure to NO2 activates plasma membrane- 
specific PLC and PLD. We have focused on PC-derived DAG 
because the PC content in plasma membranes of PAEC is 8- 
l(.-fold greater than the PI content [8]. In addition, DAG 
pr>lduction from hydrolysis of PC, but not PI, is sustained 
fo . a prolonged period of time [9,10]. PC-specific PLC activity 
is increased from 12.47 f 1.06 (control) to 21.76 & 1.20 pmol/ 
12 3 4 5 6 7 8 
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Fi+:. 1. Time-dependent effect of NOa exposure on PKC isoforms. 
(Left panel) Western blot of PKC isoforms in cytosol (lanes 14) 
and membrane (lanes 5-8) fractions of PAEC. Equal amounts of 
partially purified PKC proteins from cytosol and membrane frac- 
tions were separated by SDS-PAGE and subjected to immunoanaly- 
sis as detailed in Section 2. Lanes: 1,5, control; 2,6, 12-h NOa ex- 
posure; 3,7, 24-h NOa exposure; 4,8, 48-h NOs exposure. Shown 




Fig. 2. Results of the densitometric analyses of the Western blots of 
PKC isoforms shown in Fig. 1 in PAEC. Data represent an average 
of independent experiments. 
min per mg plasma membrane protein (NO2 exposed) (n = 5, 
p < 0.05) and PC-specific PLD activity was increased from 
78.63 f 4.08 (control) to 169.52 f 13.02 pmollmin per mg plas- 
ma membrane protein (NO2 exposed) (n = 8, p < 0.001). 
3.4. Exposure to NO2 increases PC-derived DAG generation 
A major mechanism for physiological activation of PKC 
involves the generation of DAG by hydrolysis of membrane 
phospholipids [8] Because PC represents > 60% of the total 
membrane phospholipids and NO2 exposure activates plasma 
membrane PC-specific PLC and PLD, we examined whether 
exposure to NO2 increases PC-derived DAG generation. Lipid 
analysis of endothelial cell monolayers prelabeled with 
[3H]myristic acid for 24 h showed that more than 85% of 
the total incorporated radioactivity was associated with the 
PC fraction (data not shown). As shown in Fig. 4, exposure 
to NO2 significantly increased PC-derived DAG generation in 
a time-dependent fashion @ < 0.05 versus control). 
4. Discussion 
We have previously reported that exposure to NO2 results 
in PKC activation [7] and increased biosynthesis and translo- 
cation of PS to the plasma membrane of PAEC [8,19]. The 
results of the present study demonstrate for the first time that: 
(i) PKC isoforms a, 8, and E, but not y, are expressed in 
cultured porcine PAEC; (ii) exposure to NO2 specifically in- 
creases the expression of PKC isoforms ~1, 8, and E in the 
cytosolic fraction and isoforms a and E in the membrane 
fraction; and iii) NOT-induced activation of plasma mem- 
brane PLC and PLD resulted in elevated production of 
I 
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Fig. 3. Scatchard plot of saturation binding of [3H]PDBU to homo- 
genates of NOs-exposed (1) and control cells (m). Cell monolayers 
were exposed to 5 ppm NOs in room air or room air alone (con- 
trol) for 24 h. After exposure, [3H]PDBU binding was monitored as 
described in Section 2. Data shown are representative of four ex- 
periments. 
DAG that appears to arise largely from the hydrolysis of 
membrane PC in PAEC. 
PKC exists as a family of different isoforms identified by 
molecular cloning, and the isoforms vary in their tissue dis- 
tribution and in co-factor requirements for activation. For 
example, the conventional PKC isoforms (c&r) are activated 
by calcium, PS, and DAG or PDBu. The novel PKC isoforms 
(6,~,rl,t3) are also activated by PS and DAG or PDBu but lack 
the calcium binding domain, whereas atypical PKC isoforms 
(&t,y,u) are activated by PS but not by DAG, PDBu, or 
calcium [9,20,21]. Very little is known about the distribution 
and expression of PKC isoforms in vascular endothelium. 
Previous studies have reported the presence of only a few 
selected isoform in endothelial cells derived from different 
species. For example, Leibersperger et al. [22] have identified 
PKC 6 isoform in bovine aortic, human brain, and rat cere- 
bral cortex capillary endothelial cells. More recently, Mattila 
et al. [23] and Bussolino et al. [24] have reported expression of 
PKC isoforms a, a, and E in human umbilical vein endothelial 
cells. However, none of these studies have examined the dis- 
tribution of PKC isoforms in the cytosol and membrane frac- 
tions of these cells. The results of the present study demon- 
strate the presence of PKC isoforms a and E in cytosol and 
membrane fractions, whereas isofotm B is present only in the 
cytosolic fraction of PAEC. Although the reasons for selective 
distribution and expression of a few dominant isoforms of 
PKC in vascular endothelial cells is not well understood, it 
has been suggested that different isoforms may have a specific 
physiologic role. For example, different levels of expression 
and distribution of various isoforms of PKC in mammalian 
cells have been correlated with cellular growth and differentia- 
tion [25,26], release of prolactin and arachidonate [27,28], and 
in the expression of class II antigens [29]. The specific roles of 
PKC isoforms in PAEC remain to be elucidated. 
Our results also demonstrate that NO:! exposure increases 
the expression of PKC isoforms a, l3, and E in the cytosolic 
fraction and isoforms a and E in the membrane fraction of 
PAEC. The affinity of PDBu binding determined by Scatchard 
analysis indicates that exposure to NO2 increases the number 
of PDBu binding sites and confirms our Western blot analysis 
in which exposure to NO2 resulted in increased expression of 
PKC proteins. The precise mechanism by which NO2 expo- 
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sure increases the expression of PKC proteins remains elusive. 
However, a recent report indicates that platelet-activating fac- 
tor (PAF, l-radyl-2-acetyl-sn-glycerol-3-phosphocholine), an 
oxidative product of membrane PC, increases the mRNA 
transcripts and activates the a and I3 isoforms in human en- 
dothelial cells [24]. A number of oxidants including NO2 are 
known to cause peroxidation of membrane lipids, resulting in 
structural alterations and modulation of cell functions 
[6,7,11]. As such, NOz-induced lipid peroxidation products 
may be respnsible, at least in part, for increased expression 
of PKC proteins. In addition, a recent report from our lab 
demonstrates that exposure to NOs results in upregulation of 
a number of proteins, including a 78 kDa glucose-regulated 
protein that requires de novo transcription and protein synthe- 
sis in PAEC [30]. Therefore, it is possible that NOz-induced 
oxidative injury may be responsible for upregulation of PKC 
proteins through increased protein synthesis. 
All PKC isoforms identified in vascular endothelial cells are 
known to be activated by PS and DAG. Recently, we have 
reported that exposure to NO2 increases the biosynthesis and 
translocation of PS to plasma membranes of PAEC [8] In the 
present study, we examined whether NOz-induced expression 
of PKC proteins is associated with increased production of 
DAG. We have particularly focused on DAG production be- 
cause increased PDBu binding observed in this study indicates 
the possible increase of DAG. PKCs are known to be the 
receptor proteins for PDBu, and PDBu binding mimics 
DAG binding and activation of PKC [31]. Several mechan- 
isms have been proposed for agonist- or chemical-induced 
formation of DAG in mammalial cells. For example, phos- 
pholipase-catalyzed hydrolysis of PI is known to produce a 
transient and limited amount of DAG, whereas a sustained 
increase in DAG production occurs in response to endogen- 
ous or exogenous chemicals such as mitogen-, growth factor-, 
and PDBu-induced hydrolysis of PC [9,10]. In addition, sev- 
eral lines of evidence suggest that in mammalian cells PC is 
hydrolyzed by PLC and PLD [9911]. The results of the pre- 
sent study are consistent with these reports and demonstrate 
that exposure to NOz activates plasma membrane PLC and 

















Fig. 4. Time-dependent effect of NOs exposure on PC-derived DAG 
generation. Cell monolayers were prelabeled with [3H]myristic acid 
for 24 h and then exposed to 5 ppm NOs for the indicated periods 
as described in Section 2. Data represent meanskS.E.M. (n=4). 
p < 0.05 vs control value within each exposure time. 
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with [3H]myristic acid-labelled PAEC demonstrate that 
PLC- and PLD-derived DAG arise primarily from the hydro- 
lysis of PC. Although the mechanism by which NO2 exposure 
increases PLC and PLD activities is not known, a number of 
possibilities should be considered. First, PKC plays a critical 
rctle in the regulation of cellular proteins through modulation 
0’ phosphorylation [9]. As such, increased expression of PKC 
pi otein may result in increased phosphorylation and activa- 
ti,m of PLC and PLD. Second, NO2 may be directly respon- 
siile for increased expression of PLC and PLD proteins as we 
h. ve reported for expression of the 78 kDa glucose-regulated 
protein [30]. Third, calcium concentration is known to be 
ci (tical for the catalytic activities of PLC and PLD [l 11. Oxi- 
do nt-induced injury to vascular endothelial cells is known to 
increase intracellular calcium content by increased influx of 
e> tracellular calcium as well as by mobilization of calcium 
fr ,rn intracellular stores [32]. 
In conclusion, this report has provided evidence that (1) 
exposure to NO? increases the expression of specific isoforms 
o’ PKC in cytosol and membrane fractions of PAEC and (2) 
h&-induced activation of plasma membrane PLC and PLD 
rc$ults in increased hydrolysis of phospholipids and increased 
production of PC-derived DAG. Implications of these re- 
sl onses may be crucial for activation of regulatory and de- 
fe rse mechanisms, including phosphorylation-dephosphoryla- 
ti In reactions, and protein synthesis under NO?-induced 
o idative stress. 
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